COVID-19 Updates and Information from Department of Pathology and Cell Biology
Search All News
NIH is giving out funds to develop seven new testing technologies which could increase testing capacity around the U.S. Daniel Green, MD, was quoted in this article about the RADx program.
They gave scientific presentations covering COVID-19 and non-COVID-19 basic science topics as well as their most current research.
Source:CISION PR Newswire
Kedrion Biopharma, a leading international biopharmaceutical company, partners with Columbia University Irving Medical Center to accelerate the development of an anti-COVID IgG therapy.
Source:American Society for Investigative PathologyJune 3, 2020
Members of the Columbia University Department of Pathology & Cell Biology are leading local and state-wide efforts for a safe and staged approach to operations recovery ....
- June 2, 2020
We provide an overview of convalescent plasma, including evidence of benefit, regulatory considerations, logistical work flow and proposed clinical trials.
Source:Journal of Clinical MicrobiologyMay 14, 2020
Bacteremia is very rare among COVID-19 patients, but blood cultures are overutilized. Consider shortening the incubation period from 5 days to 4 days to free additional capacity.
Source:ScienceDirectMay 14, 2020
Abbott ID Now has limited sensitivity for COVID-19 clinical specimens in transport media with low viral loads, the study shows.
Source:CBS New YorkMay 3, 2020
The elite pilots streaking low over New York and Philadelphia posed a striking thank you to front-line workers like Dr. Sarah Vossoughi, a clinical pathologist at NewYork-Presbyterian/Columbia.
Source:MedPage TodayApril 22, 2020
New York Presbyterian uses two different tests; validation remains a "free-for-all"
Source:CBS New YorkApril 21, 2020
"Between 14 and 28 days after resolution of symptoms, we and others have found up to 30 % of individuals are still positive by the nasal swab, and they have antibodies too,” said Dr. Spitalnik.
Source:FPCApril 15, 2020
FPC Briefing with Dr, Eldad A. Hod, MD, associate professor of pathology an cell biology, and Diana Berrent, COVID-19 survivor and founder of Survivor Corps.